|
1
|
Bacon PA: The spectrum of Wegener's
granulomatosis and disease relapse. N Engl J Med. 352:330–332.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim SH, Park J, Bae JH, Cho MS, Park KD
and Jeong JH: ANCA-negative Wegener's granulomatosis with multiple
lower cranial nerve palsies. J Korean Med Sci. 28:1690–1696. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Armani M, Spinazzi M, Andrigo C, Fassina
A, Mantovan M and Tavolato B: Severe dysphagia in lower cranial
nerve involvement as the initial symptom of Wegener's
granulomatosis. J Neurol Sci. 263:187–190. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fauci AS and Wolff SM: Wegener's
granulomatosis: Studies in eighteen patients and a review of the
literature. Medicine (Baltimore). 52:535–561. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smith RM, Jones RB and Jayne DR: Progress
in treatment of ANCA-associated vasculitis. Arthritis Res Ther.
14:2102012. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Venhoff N, Effelsberg NM, Salzer U,
Warnatz K, Peter HH, Lebrecht D, Schlesier M, Voll RE and Thiel J:
Impact of rituximab on immunoglobulin concentrations and B cell
numbers after cyclophosphamide treatment in patients with
ANCA-associated vasculitides. PLoS One. 7:e376262012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pankhurst T, Savage CO, Gordon C and
Harper L: Malignancy is increased in ANCA-associated vasculitis.
Rheumatology (Oxford). 43:1532–1535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Faurschou M, Sorensen IJ, Mellemkjaer L,
Loft AG, Thomsen BS, Tvede N and Baslund B: Malignancies in
Wegener's granulomatosis: Incidence and relation to
cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol.
35:100–105. 2008.PubMed/NCBI
|
|
9
|
Russell KA, Fass DN and Speks U: Clinical
and prognostic value of antineutrophil cytoplasmic antibodies in
Wegener's granulomatosis and microscopic polyangiitis : Comment on
the article by Russell et al. Arthritis and Rheumatology.
46:278–280. 2002. View Article : Google Scholar
|
|
10
|
Fujimoto S, Watts RA, Kobayashi S, Suzuki
K, Jayne DR, Scott DG, Hashimoto H and Nunoi H: Comparison of the
epidemiology of anti-neutrophil cytoplasmic antibody-associated
vasculitis between Japan and U.K. Rheumatology (Oxford).
50:1916–1920. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mohammad AJ, Jacobsson LT, Westman KW,
Sturfelt G and Segelmark M: Incidence and survival rates in
Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss
syndrome and polyarteritis nodosa. Rheumatology (Oxford).
48:1560–1565. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jennette JC, Falk RJ, Bacon PA, Basu N,
Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L and
Hagen EC: 2012 revised International Chepel Hill Consensus
Conference Nomenclature of Vasculitides. Arthritis Rheum. 65:1–11.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pagnoux C: Updates in ANCA-associated
vasculitis. Eur J Rheumatol. 3:122–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Capuano G, Grosso A, Gentile PC, Battista
M, Bianciardi F, Di Palma A, Pavese I, Satta F, Tosti M, Palladino
A, et al: Influence of weight loss on outcomes in patients with
head and neck cancer undergoing concomitant chemoradiotherapy. Head
Neck. 30:503–508. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Paccagnella A, Morello M, Da Mosto MC,
Baruffi C, Marcon ML, Gava A, Baggio V, Lamon S, Babare R, Rosti G,
et al: Early nutritional intervention improves treatment tolerance
and outcomes in head and neck cancer patients undergoing concurrent
chemoradiotherapy. Support Care Cancer. 18:837–845. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luk YS, Shum JSF, Sze HCK, Chan LL, Ng WT
and Lee AW: Predictive factors and radiological features of
radiation-induced cranial nerve palsy in patients with
nasopharyngeal carcinoma following radical radiotherapy. Oral
Oncol. 49:49–54. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cattaneo L, Chierici E, Pavone L,
Grasselli C, Manganelli P, Buzio C and Pavesi G: Peripheral
neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and
microscopic polyangiitis. J Neurol Neurosurg Psychiatry.
78:1119–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chiarugi G and Bucciante L: Istituzioni di
Anatomia dell'Uomo. 10th. Vallardi, Milan: pp. 719–743. 1968-1972,
(In Italian).
|
|
19
|
Nishino H, Rubino FA, DeRemee RA, Swanson
JW and Parisi JE: Neurological involvement in Wegener's
granulomatosis: An analysis of 324 consecutive patients at the Mayo
Clinic. Ann Neurol. 33:4–9. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kashiyama T, Suzuki A and Mizuguchi K:
Wegener's granulomatosis with multiple cranial nerve involvements
as the initial clinical manifestations. Intern Med. 34:1110–1113.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nölle B, Specks U, Lüdemann J, Rohrbach
MS, DeRemee RA and Gross WL: Anticytoplasmic autoantibodies: Their
immunodiagnostic value in Wegener granulomatosis. Ann Intern Med.
111:28–40. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Finkielman JD, Lee AS, Hummel AM, Viss MA,
Jacob GL, Homburger HA, Peikert T, Hoffman GS, Merkel PA, Spiera R,
et al: WGET Research Group: ANCA are detectable in nearly all
patients with active severe Wegener's granulomatosis. Am J Med.
120:643.e9–643.e14. 2007. View Article : Google Scholar
|
|
23
|
Aries PM, Hellmich B, Voswinkel J, Both M,
Nölle B, Holl-Ulrich K, Lamprecht P and Gross WL: Lack of efficacy
of rituximab in Wegener's granulomatosis with refractory
granulomatous manifestations. Ann Rheum Dis. 65:853–858. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Omdal R, Wildhagen K, Hansen T, Gunnarsson
R and Kristoffersen G: Anti-CD20 therapy of treatment-resistant
Wegener's granulomatosis: Favourable but temporary response. Scand
J Rheumatol. 34:229–232. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hebert LA, Ardoin S and Shim RL: Rituximab
or cyclophosphamide in ANCA-associated renal vasculitis. N Engl J
Med. 363:2073–2074. 2010.PubMed/NCBI
|
|
26
|
Besada E, Koldingsnes W and Nossent JC:
Serum immunoglobulin levels and risk factors for
hypogammaglobulinaemia during long-term maintenance therapy with
rituximab in patients with granulomatosis with polyangiitis.
Rheumatology (Oxford). 53:1818–1824. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jones RB, Ferraro AJ, Chaudhry AN, Brogan
P, Salama AD, Smith KGC, Savage CO and Jayne DR: A multicenter
survey of rituximab therapy for refractory antineutrophil
cytoplasmic antibody-associated vasculitis. Arthritis Rheum.
60:2156–2168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jones RB, Tervaert JW, Hauser T, Luqmani
R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen
P, et al; European vasculitis study group, . Rituximab versus
cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med.
363:211–220. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stone JH, Merkel PA, Spiera R, Seo P,
Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A,
Tchao NK, et al; RAVE-ITN Research Group, . Rituximab versus
cyclophosphamide for ANCA-associated vasculitis. N Engl J Med.
363:221–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Looney RJ: B cells as a therapeutic target
in autoimmune diseases other than rheumatoid arthritis.
Rheumatology (Oxford). 44 Suppl 2:ii13–ii17. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thiel J, Rizzi M, Engesser M, Dufner AK,
Troilo A, Lorenzetti R, Voll RE and Venhoff N: B cell repopulation
kinetics after rituximab treatment in ANCA-associated vasculitides
compared to rheumatoid arthritis, and connective tissue diseases: A
longitudinal observational study on 120 patients. Arthritis Res
Ther. 19:1012017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stein J, Sridharan ST, Eliachar I, Niv A,
Wood B and Hoffman GS: Nasal cavity squamous cell carcinoma in
Wegener's granulomatosis. Arch Otolaryngol Head Neck Surg.
127:709–713. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kuan EC, Peng KA, Gonzales LO and Sercarz
JA: A case of squamous cell carcinoma of the nasal cavity in a
patient with granulomatosis with polyangiitis (Wegener
granulomatosis). Ear Nose Throat J. 97:E37–E41. 2018.PubMed/NCBI
|
|
34
|
Silva F, Seo P, Schroeder D, Stone JH,
Merkel PA, Hoffman GS, Spiera R, Sebastian JK, Davis JC Jr, St
Clair EW, et al: Solid malignancies among patients with Wegener's
granulomatosis treated with Etarnercept: Long-term follow-up of a
multicenter longitudinal cohort. Arthritis Rheum. 63:2495–2503.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pignon JP, le Maître A, Maillard E and
Bourhis J; MACH-NC Collaborative Group, . Meta-analysis of
chemotherapy in head and neck cancer (MACH-NC): An update on 93
randomised trials and 17,346 patients. Radiother Oncol. 92:4–14.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Forastiere AA, Zhang Q, Weber RS, Maor MH,
Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, et
al: Long-term results of RTOG 91-11: A comparison of three
nonsurgical treatment strategies to preserve the larynx in patients
with locally advanced larynx cancer. J Clin Oncol. 31:845–852.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lin A, Abu-Isa E, Griffith KA and
Ben-Josef E: Toxicity of radiotherapy in patients with collagen
vascular disease. Cancer. 113:648–653. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Neviani CB, Carvalho HA, Hossamu C, Aisen
S and Nadalin W: Radiation therapy as an option for upper airway
obstruction due to Wegener's granulomatosis. Otolaryngol Head Neck
Surg. 126:195–196. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wygoda A, Rutkowski T, Składowski K and
Hejduk B: Low dose radiotherapy as an effective treatment in a
patient with solitary Wegener's granulomatosis resistant to
systemic treatment - case report. Contemp Oncol (Pozn). 17:107–111.
2013.PubMed/NCBI
|
